NMT targets heart repair implant at migraine therapy arena
This article was originally published in Clinica
NMT Medical is to assess whether its minimally invasive implant for repairing cardiac defects might also have application in the potential multi-billion dollar migraine headache therapy market.
You may also be interested in...
Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.
President Trump on 27 March finally pulled the trigger on using his powers under the Defense Production Act, forcing General Motors Co. to manufacture medical ventilators. The only thing is, GM is already doing that.
Theradaptive's “paint-like” regenerative therapeutic can be applied to any device to promote bone regrowth or regenerate tissue.